中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
FMOC-(R)-3-氨基-3-(3-三氟甲基苯基)-丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid |
517905-87-2 |
C25H20F3NO4 |
|
FMOC-(R)-3-氨基-3-(2-甲氧基苯基)-丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methoxyphenyl)propanoic acid |
511272-31-4 |
C25H23NO5 |
|
FMOC-(R)-3-氨基-3-(2-氟苯基)-丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid |
511272-50-7 |
C24H20FNO4 |
|
FMOC-(R)-3-氨基-3-(2-三氟甲基苯基)-丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid |
517905-86-1 |
C25H20F3NO4 |
|
FMOC-(R)-3-氨基-3-(2,3-二氯苯基)-丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid |
511272-38-1 |
C24H19Cl2NO4 |
|
FMOC-(R)-2-(2-噻吩基)-甘氨酸 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-2-yl)acetic acid |
211682-13-2 |
C28H28NO5Pol |
|
FMOC-(4-氨甲基)苯甲酸 |
N-(9-fluorenylmethyloxycarbonyl)-4-(aminomethyl)benzoic acid |
164470-64-8 |
C23H19NO4 |
|
FMOC-(3S,4S)-4-氨基-3-羟基戊酸二环己铵盐 |
Fmoc-(3S,4S)-4-amino-3-hydroxy-pentanoic acid dicyclohexylammonium salt |
204316-31-4 |
C32H44N2O5 |
|
FMOC-(3S,4S)-4-氨基-3-羟基-5-苯基戊酸 |
Fmoc-(3 S,4 S)-4-amino-3-hydroxy-5-phenylpentanoic acid |
198542-01-7 |
C26H25NO5 |
|
FMOC-(3S)-3-1-羧甲基-2-戊内酰胺 |
[(S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-oxo-piperidin-1-yl]-acetic acid |
215190-25-3 |
C22H22N2O5 |
|
FMOC-(2S,6S,9S)-6-氨基-2-羧甲基-3,8-二氮杂双环(4,3,0)壬烷-1,4-二酮 |
[(3S,7S,8aS)-7-(9H-Fluoren-9-ylmethoxycarbonylamino)-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazin-3-yl]-acetic acid |
184700-26-3 |
C24H23N3O6 |
|
FMOC-(2R,4S)-4-羟基吡咯烷-2-羧酸 |
N-Fmoc 4-hydroxypropline |
139262-20-7 |
C20H19NO5 |
|
FLUO3五胺盐 |
Fluo-3 (pentaammonium) |
—— |
C36H45Cl2N7O13 |
|
FK506束缚蛋白质-25 |
4-Amino-N-(hexahydro-1-methyl-2H-azepin-2-ylidene)benzenesulfonamide |
126826-62-8 |
C13H19N3O2S |
|
FK-506一水合物 |
Tacrolimus monohydrate |
109581-93-3 |
C44H71NO13 |
|
FIBRINOGEN-BINDING肽 |
Glutamyl-histidyl-isoleucyl-prolyl-alanine |
137235-80-4 |
C25H39N7O8 |
|
FGFR抑制剂(NVP-BGJ398) |
BGJ398 |
872511-34-7 |
C26H31Cl2N7O3 |
|
FGFR1酪氨酸激酶抑制剂(PD-166866) |
PD 166866 |
192705-79-6 |
C20H24N6O3 |
|
FERROVANADIUM合金) |
vanadium iron powder |
11147-86-7 |
FeV |
|
FAVIPIRAVIR杂质14 |
3-chloro-6-fluoro-2-pyrazinecarbonitrile |
356783-49-8 |
C5HClFN3 |
|
FAS活化的丝/苏氨酸激酶抗体 |
Fas-activated serine/threonine kinase |
170347-50-9 |
—— |
——
|
FAM炔烃6异构体 |
6-(prop-2-yn-1-yl)carbamoylfluorescein |
478801-49-9 |
C24H15NO6 |
|
FAM叠氮化物,6-异构体 |
N-(3-azidoprop-1-yl)fluoresceinyl-6-carboxamide |
1386385-76-7 |
C24H18N4O6 |
|
FA-丙氨酰精氨酸-OH |
N-[3-(2-Furanyl)-1-oxo-2-propen-1-yl]-L-alanyl-L-arginine |
76079-06-6 |
C16H23N5O5 |
|
F1-20蛋白质 |
3-Ethyl-2-methylquinoxalin-5-amine |
126987-75-5 |
C11H13N3 |
|
F-去甲立蒽 |
F-Nor-steranthren |
3570-54-5 |
C22H16 |
|
Ethyl 5-氨基-4-氰基-3-甲基-2-噻吩羧酸乙酯 |
ethyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate |
23903-46-0 |
C9H10N2O2S |
|
Esomeprazole镁盐水合物 |
(S)-Omeprazole magnesium;(-)-Omeprazole magnesium |
668985-31-7 |
C34H38MgN6O7S2 |
|
Erythristemine; (3beta,11alpha)-1,2,6,7-四去氢-3,11,15,16-四甲氧基刺桐烷 |
(+/-)-erythristemine |
28619-41-2 |
C20H25NO4 |
|
ErythrininC;2,3-二氢-4-羟基-2-(1-羟基-1-甲基乙基)-6-(4-羟基苯基)-5H-呋喃并[3,2-g][1]苯并吡喃-5-酮 |
erythrinin C |
63807-85-2 |
C20H18O6 |
|
Erysotramidine; (3beta)-1,2,6,7-四去氢-3,15,16-三甲氧基刺桐烷-8-酮 |
(+)-erysotramidine |
52358-58-4 |
C19H21NO4 |
|
Ervamycine; 11-甲氧基水甘草碱 |
11-methoxytabersonine |
27773-39-3 |
C22H26N2O3 |
|
Emixustat盐酸盐 |
emixustat hydrochloride |
1141934-97-5 |
C16H25NO2*ClH |
|
Elacestrant 二盐酸盐 |
Elacestrant hydrochloride |
1349723-93-8 |
C30H40Cl2N2O2 |
|
Egenine; (6R,8S)-6,8-二氢-6-[(5S)-5,6,7,8-四氢-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基]呋喃并[3,4-e]-1,3-苯并二氧杂环戊烯-8-醇 |
(+)-egenine |
6883-44-9 |
C20H19NO6 |
|
Eg5抑制剂VII |
6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-quinolin-2-one |
912953-25-4 |
C16H12F3NO |
|
Eg5抑制剂IV,VS-83 |
Eg5 Inhibitor IV, VS-83 |
909250-29-9 |
C14H11FN2OS |
|
EZH2甲基转移酶抑制剂(GSK126) |
GSK-126 |
1346574-57-9 |
C31H38N6O2 |
|
EZATIOSTAT游离的 |
γ-glutamyl-S-(benzyl)cysteinyl-(R)-(-)-phenylglycine diethyl ester |
168682-53-9 |
C27H35N3O6S |
|
EVACETRAPIB中间体 |
methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate |
1259393-27-5 |
C14H17NO3 |
|
ETHYL4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-1-THIO-Β-D-GLUCOPYRANOSIDE乙基4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚氨基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside |
99409-33-3 |
C23H23NO6S |
|
ETHYL3-O-(2-NAPHTHYL)METHYL-4,6-O-BENZYLIDENE-1-THIO-Β-D-GLUCOPYRANOSIDE乙基3-O-(2-萘基)甲基-4,6-O-亚苄基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside |
352008-09-4 |
C26H28O5S |
|
ETHYL 5-硝基-2-吡啶乙基甲苯 |
ethyl 5-nitropicolinate |
30563-98-5 |
C8H8N2O4 |
|
ESTRATETRAENONE甲酯 |
Equilin 3-methyl ether |
6030-83-7 |
C19H22O2 |
|
ERRΒ/Γ激动剂(GSK-4716) |
(E)-N'-(4-(diethylamino)benzylidene)-4-hydroxybenzohydrazide |
95167-41-2 |
C18H21N3O2 |
|
ERK抑制剂II,阴性对照 |
ERK Inhibitor II, Negative Control |
1177970-73-8 |
C18H12N6O |
|
EPZ005687抑制剂 |
EPZ005687 |
1396772-26-1 |
C32H37N5O3 |
|
EPSILON-(GAMMA-L-谷氨酰)-L-赖氨酸 |
epsilon-(gamma-glutamyl)lysine |
17105-15-6 |
C11H21N3O5 |
|
EPA乙酯 |
Methyl (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoate |
28061-46-3 |
C23H34O2 |
|
EPA乙酯 |
eicosapentaenoic acid ethyl ester |
86227-47-6 |
C22H34O2 |
|